$0.7601
-0.0158[-2.04%]
At close: May 21
$0.7601
0[0.00%]
PreMarket: 4:09PM EDT
Kezar Life Sciences
(NASDAQ:KZR)Kezar Life Sciences Stock (NASDAQ:KZR), Analyst Ratings, Price Targets, Predictions
Kezar Life Sciences Inc has a consensus price target of $7.2, established from looking at the 23 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on May 10, 2024, March 15, 2024, and December 4, 2023. With an average price target of $20 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 2531.23% upside for Kezar Life Sciences Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Wells Fargo
JonesTrading
William Blair
JonesTrading
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Kezar Life Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/10/2024 | Buy Now | 2531.23% | HC Wainwright & Co. | Raghuram Selvaraju | → $20 | Reiterates | Buy → Buy | Get Alert |
| 03/15/2024 | Buy Now | 2531.23% | HC Wainwright & Co. | Raghuram Selvaraju | → $20 | Reiterates | Buy → Buy | Get Alert |
| 12/04/2023 | Buy Now | 2531.23% | HC Wainwright & Co. | Raghuram Selvaraju | → $20 | Reiterates | Buy → Buy | Get Alert |
| 11/27/2023 | Buy Now | 2531.23% | HC Wainwright & Co. | Raghuram Selvaraju | → $20 | Reiterates | Buy → Buy | Get Alert |
| 11/14/2023 | Buy Now | 163.12% | Wells Fargo | Derek Archila | $4 → $2 | Maintains | Equal-Weight | Get Alert |
| 10/12/2023 | Buy Now | 2531.23% | HC Wainwright & Co. | Raghuram Selvaraju | → $20 | Reiterates | Buy → Buy | Get Alert |
| 10/05/2023 | Buy Now | — | JonesTrading | Catherine Novack | — | Downgrade | Buy → Hold | Get Alert |
| 09/25/2023 | Buy Now | 2531.23% | HC Wainwright & Co. | Raghuram Selvaraju | $18 → $20 | Maintains | Buy | Get Alert |
| 08/11/2023 | Buy Now | — | Wells Fargo | Derek Archila | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/11/2023 | Buy Now | 2268.11% | HC Wainwright & Co. | Raghuram Selvaraju | $19 → $18 | Maintains | Buy | Get Alert |
| 05/12/2023 | Buy Now | 2399.67% | HC Wainwright & Co. | Raghuram Selvaraju | $21 → $19 | Maintains | Buy | Get Alert |
| 05/12/2023 | Buy Now | 1610.3% | Wells Fargo | Derek Archila | $14 → $13 | Maintains | Overweight | Get Alert |
| 03/16/2023 | Buy Now | — | William Blair | Matt Phipps | — | Downgrade | Outperform → Market Perform | Get Alert |
| 03/16/2023 | Buy Now | 2662.79% | HC Wainwright & Co. | Raghuram Selvaraju | → $21 | Reiterates | → Buy | Get Alert |
| 01/03/2023 | Buy Now | 1741.86% | Wells Fargo | Derek Archila | $17 → $14 | Maintains | Overweight | Get Alert |
| 08/12/2022 | Buy Now | 2662.79% | HC Wainwright & Co. | Raghuram Selvaraju | $20 → $21 | Maintains | Buy | Get Alert |
| 06/28/2022 | Buy Now | 2136.55% | Wells Fargo | Derek Archila | $13 → $17 | Maintains | Overweight | Get Alert |
| 05/13/2022 | Buy Now | 1610.3% | Wells Fargo | Derek Archila | $14 → $13 | Maintains | Overweight | Get Alert |
| 05/04/2022 | Buy Now | 1741.86% | Wells Fargo | Derek Archila | $19 → $14 | Maintains | Overweight | Get Alert |
| 03/18/2022 | Buy Now | 2794.36% | HC Wainwright & Co. | Raghuram Selvaraju | $20 → $22 | Maintains | Buy | Get Alert |
| 12/08/2021 | Buy Now | 2399.67% | Wells Fargo | Derek Archila | — | Initiates | → Overweight | Get Alert |
| 11/16/2021 | Buy Now | 2531.23% | HC Wainwright & Co. | Raghuram Selvaraju | — | Maintains | Buy | Get Alert |
| 07/20/2021 | Buy Now | 1741.86% | JonesTrading | — | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Kezar Life Sciences (KZR)?
The latest price target for Kezar Life Sciences (NASDAQ: KZR) was reported by HC Wainwright & Co. on May 10, 2024. The analyst firm set a price target for $20.00 expecting KZR to rise to within 12 months (a possible 2531.23% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kezar Life Sciences (KZR)?
The latest analyst rating for Kezar Life Sciences (NASDAQ: KZR) was provided by HC Wainwright & Co., and Kezar Life Sciences reiterated their buy rating.
When was the last upgrade for Kezar Life Sciences (KZR)?
There is no last upgrade for Kezar Life Sciences.
When was the last downgrade for Kezar Life Sciences (KZR)?
The last downgrade for Kezar Life Sciences Inc happened on October 5, 2023 when JonesTrading changed their price target from N/A to N/A for Kezar Life Sciences Inc.
When is the next analyst rating going to be posted or updated for Kezar Life Sciences (KZR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kezar Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kezar Life Sciences was filed on May 10, 2024 so you should expect the next rating to be made available sometime around May 10, 2025.
Is the Analyst Rating Kezar Life Sciences (KZR) correct?
While ratings are subjective and will change, the latest Kezar Life Sciences (KZR) rating was a reiterated with a price target of $0.00 to $20.00. The current price Kezar Life Sciences (KZR) is trading at is $0.76, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.